Explore

Rapid Read Rapid Read
Parkinson's Advocacy Groups Urge Congress to Increase NIH Funding Amid Budget Cuts

Parkinson's Advocacy Groups Urge Congress to Increase NIH Funding Amid Budget Cuts

Three leading Parkinson's advocacy organizations are urging Congress to increase funding for Parkinson's research at the National Institutes of Health (NIH) as the President's federal budget proposal for Fiscal Year 2027 includes a $5 billion reduction in NIH funding. The American Parkinson Disease Association, The Michael J. Fox Foundation for Parkinson's Research, and The Parkinson's Foundation are advocating for an annual investment of $600 million in Parkinson's research. This request comes as the economic burden of Parkinson's disease in the U.S. totals $82.2 billion annually. The organizations emphasize the importance of continued federal investment to support scientific breakthroughs and treatments for Parkinson's and related neurodegenerative diseases.
Rapid Read Rapid Read
Parkinson's Advocacy Groups Urge Congress to Boost NIH Research Funding Amid Proposed Cuts

Parkinson's Advocacy Groups Urge Congress to Boost NIH Research Funding Amid Proposed Cuts

Three leading national Parkinson's advocacy organizations are urging Congress to increase funding for Parkinson's research at the National Institutes of Health (NIH) as part of the federal budget for Fiscal Year 2027. This call comes in response to a proposed $5 billion reduction in NIH funding, which the groups argue would hinder scientific progress crucial for the 1.2 million Americans living with Parkinson's disease. The American Parkinson Disease Association, The Michael J. Fox Foundation for Parkinson's Research, and The Parkinson's Foundation are advocating for an annual federal investment of $600 million in Parkinson's research. This amount is less than 1% of the $82.2 billion annual economic burden of the disease. The organizations emphasize the importance of continued bipartisan support for NIH funding, which has historically driven significant advancements in Parkinson's treatment and research.
Rapid Read Rapid Read
Leading Parkinson's Organizations Urge Congress to Increase NIH Research Funding

Leading Parkinson's Organizations Urge Congress to Increase NIH Research Funding

Three major Parkinson's advocacy organizations are urging Congress to increase funding for Parkinson's research at the National Institutes of Health (NIH). This call comes as Congress reviews the President's federal budget proposal for Fiscal Year 2027, which includes a $5 billion reduction in NIH funding. The organizations, representing 1.2 million Americans with Parkinson's, are advocating for an increase to $600 million annually for Parkinson's research. This funding level is less than 1% of the annual economic burden of Parkinson's, which totals $82.2 billion. The advocacy groups emphasize the importance of continued federal investment to support scientific breakthroughs and improve treatments for Parkinson's and related neurodegenerative diseases.
Trendline Trendline
Kopernik Global Investors Increases Stake in Northern Dynasty Minerals Amid Regulatory Challenges

Kopernik Global Investors Increases Stake in Northern Dynasty Minerals Amid Regulatory Challenges

Kopernik Global Investors Increases Stake in Northern Dynasty Minerals Amid Regulatory Challenges
Rapid Read Rapid Read
Research Links Shingles Vaccine to Reduced Dementia Risk and Slower Aging

Research Links Shingles Vaccine to Reduced Dementia Risk and Slower Aging

Recent studies have highlighted potential additional benefits of the shingles vaccine beyond its primary purpose of preventing shingles. Research published in the Journals of Gerontology suggests that individuals who received the shingles vaccine exhibited slower biological aging compared to those who did not. Furthermore, emerging research indicates a possible protective effect against dementia. The studies, while showing correlation rather than causation, suggest that the vaccine may help control aging at a molecular level by reducing inflammation, a key factor in aging and disease development. The current shingles vaccine, Shingrix, is noted to be more effective than its predecessor, Zostavax, which was discontinued in the U.S. in 2020.
Rapid Read Rapid Read
American Library Association Mobilizes Against Proposed Federal Funding Cuts

American Library Association Mobilizes Against Proposed Federal Funding Cuts

The American Library Association (ALA) is actively opposing President Trump's proposed federal budget for fiscal 2027, which aims to eliminate funding for the Institute of Museum and Library Services (IMLS) and the school library program Innovative Approaches to Literacy (IAL). The ALA has issued a statement condemning these cuts and is rallying its members to advocate for continued federal support. This move follows a pattern of previous attempts by the Trump administration to cut library funding, which the ALA and other organizations have successfully blocked in the past. The ALA is currently urging its members to contact their senators to support federal funding for libraries.
Rapid Read Rapid Read
Trump Administration Proposes Significant Funding Cuts to NOAA, Sparking Concerns

Trump Administration Proposes Significant Funding Cuts to NOAA, Sparking Concerns

The Trump Administration has proposed a $1.6 billion funding cut to the National Oceanic and Atmospheric Administration (NOAA) as part of its fiscal year 2027 budget. This proposal targets climate research programs and educational grants, which the administration claims are not aligned with its policy of ending 'Green New Scam' initiatives. Experts warn that these cuts could undermine public safety by affecting weather forecasts, emergency storm alerts, and critical preparedness programs. The cuts could also jeopardize industries such as energy, agriculture, fishing, tourism, and transportation, which rely on NOAA's services for accurate weather forecasts and data.
Rapid Read Rapid Read
Research Highlights Impact of Insurance on Cancer Survival Among Young Adults

Research Highlights Impact of Insurance on Cancer Survival Among Young Adults

Recent research underscores the significant role that insurance status plays in cancer survival rates among young adults in the United States. A comprehensive review of scientific literature, involving nearly 470,000 Americans aged 15 to 39 diagnosed with cancer, reveals that those with private health insurance have a survival advantage over those on Medicaid or without insurance. This advantage varies by cancer type, with private insurance reducing the risk of death by 8% for lymphoma and up to 2.5 times for melanoma and other cancers. The study highlights the instability of health coverage for young adults, who often lose insurance when they turn 26 or start jobs without benefits, leaving many uninsured or underinsured. This instability exacerbates the already slower improvements in cancer survival rates for this age group compared to children and older adults.
Trendline Trendline
Brookstone Capital Management Increases Hecla Mining Holdings by Over 650%

Brookstone Capital Management Increases Hecla Mining Holdings by Over 650%

Brookstone Capital Management Increases Hecla Mining Holdings by Over 650%
Rapid Read Rapid Read
White House Proposes 12.5% Budget Cut for HHS in FY2027 Amid Reorganization Plans

White House Proposes 12.5% Budget Cut for HHS in FY2027 Amid Reorganization Plans

The White House has proposed a $15.8 billion discretionary budget cut for the Department of Health and Human Services (HHS) for fiscal year 2027. This represents a 12.5% decrease from the current fiscal year's budget. The proposed cuts are part of a broader reorganization plan aimed at increasing efficiency by consolidating subagencies under a new body called the Administration for a Healthy America (AHA). The plan includes eliminating programs deemed duplicative or misaligned with the administration's policies, such as those promoting diversity, equity, and inclusion ideologies. Additionally, the proposal includes significant reductions in funding for the National Institutes of Health (NIH) and other health-related programs.
Trendline Trendline
Brookstone Capital Increases Stake in Hecla Mining, Signaling Confidence in Precious Metals

Brookstone Capital Increases Stake in Hecla Mining, Signaling Confidence in Precious Metals

Brookstone Capital Increases Stake in Hecla Mining, Signaling Confidence in Precious Metals
Rapid Read Rapid Read
Japanese Fruit Sarunashi Shows Potential in Preventing Lung Cancer in Mice

Japanese Fruit Sarunashi Shows Potential in Preventing Lung Cancer in Mice

Researchers at Okayama University have identified a small Japanese fruit, Sarunashi (Actinidia arguta), also known as the kiwiberry, as a potential agent in preventing lung cancer. In a study published in the journal Genes and Environment, the fruit's juice was found to reduce lung tumor formation in mice exposed to NNK, a carcinogen related to tobacco. The juice also decreased the number of tumor nodules in the lungs, and its compound isoquercetin demonstrated protective effects. The study suggests that Sarunashi juice may interfere with the initiation and growth of cancer by reducing DNA damage and supporting DNA repair mechanisms. While these findings are promising, clinical trials are necessary to confirm the fruit's efficacy in humans.